JUN 21, 2018 09:00 AM PDT

Can AI Beat Cancer?

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Founder and Chairman at Cancer Commons
    Biography
      Dr. Jay M. ("Marty") Tenenbaum, a world-renowned Internet commerce pioneer and visionary, founded CommerceNet (1994) to accelerate business use of the Internet. While at CommerceNet, he co-founded Veo Systems (1997), the company that pioneered the use of XML for automating business-to-business transactions. When Commerce One acquired Veo Systems in January 1999, Dr. Tenenbaum became chief scientist and was instrumental in shaping the company's business and technology strategies for the Global Trading Web.

      Post Commerce One, Dr. Tenenbaum was an officer and director of Webify Solutions (sold to IBM in 2006) and Medstory (sold to Microsoft in 2007). Currently, his focus is on transforming healthcare and accelerating therapy development through collaborative e-science. Towards that end, he founded CollabRx, which builds "virtual biotechs" to help slash the time, cost, and risk of developing new therapies."

      Prior to CommerceNet, he was founder and CEO of Enterprise Integration Technologies, the first company to conduct a commercial Internet transaction (1992), secure Web transaction (1993), and Internet auction (1993). Earlier in his career, Dr. Tenenbaum was also a prominent AI researcher, and led AI research groups at SRI International and Schlumberger Ltd.

      Dr. Tenenbaum is a fellow and former board member of the American Association for Artificial Intelligence, and a former consulting professor of Computer Science at Stanford. He currently serves as a director of Efficient Finance, Patients Like Me, and the Public Library of Science, and is a consulting professor of Information Technology at Carnegie Mellon's new West coast campus.

      Dr. Tenenbaum holds B.S. and M.S. degrees in Electrical Engineering from MIT, and a Ph.D. from Stanford.

    Abstract:

    Finding effective treatments for cancer is fundamentally  a high-dimensional probabilistic planning, search, and optimization problem, characterized by  thousands of molecular subtypes,  tens of thousands of plausible drug regimens, and a dearth of high quality data on clinical responses.  These explosive combinatorics and the lack of data are overwhelming traditional approaches to clinical development, including the latest Bayesian adaptive trial designs and big data analytics.  However, this is precisely the kind of knowledge-based  planning and search problem that AI is uniquely designed to solve.  Many organizations are developing relevant AI-based applications, from decision support and treatment planning to treatment validation and real time response monitoring.  We will review these developments and describe a bold industry-wide initiative to integrate them for the immediate benefit of all cancer patients and their physicians, while radically improving the efficiency of clinical research and drug development. 


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    Loading Comments...
    Show Resources